| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
48,471 |
39,992 |
$1.55M |
| 87428 |
|
8,723 |
8,031 |
$459K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,836 |
6,206 |
$322K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,280 |
5,156 |
$202K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,558 |
2,463 |
$160K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,200 |
2,147 |
$147K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,342 |
3,035 |
$62K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,868 |
1,374 |
$44K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,209 |
996 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,537 |
1,308 |
$29K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
413 |
402 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,621 |
2,498 |
$23K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
442 |
368 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,031 |
884 |
$17K |
| 87807 |
|
663 |
598 |
$5K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
103 |
79 |
$5K |
| 99381 |
|
59 |
58 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
1,390 |
1,211 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
44 |
41 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
57 |
53 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
167 |
150 |
$2K |
| 90686 |
|
170 |
160 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
139 |
130 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
31 |
25 |
$1K |
| 90670 |
|
1,888 |
1,847 |
$1K |
| 95117 |
|
82 |
25 |
$781.11 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
178 |
161 |
$734.05 |
| 90698 |
|
1,631 |
1,596 |
$596.52 |
| 90633 |
|
398 |
379 |
$552.50 |
| 90680 |
|
1,232 |
1,203 |
$509.80 |
| 71046 |
Radiologic examination, chest; 2 views |
28 |
26 |
$426.01 |
| 83655 |
|
24 |
24 |
$318.28 |
| 90688 |
|
90 |
86 |
$132.12 |
| 90651 |
|
17 |
14 |
$130.90 |
| 90744 |
|
411 |
397 |
$125.34 |
| 90647 |
|
194 |
189 |
$114.77 |
| 90723 |
|
189 |
186 |
$92.00 |
| 90687 |
|
66 |
64 |
$69.55 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
487 |
434 |
$68.70 |
| 81003 |
|
260 |
231 |
$66.89 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
43 |
38 |
$60.48 |
| 85018 |
|
26 |
26 |
$53.42 |
| 3074F |
|
2,772 |
2,468 |
$0.00 |
| 3075F |
|
519 |
469 |
$0.00 |
| 3079F |
|
1,314 |
1,178 |
$0.00 |
| 91301 |
|
14 |
13 |
$0.00 |
| 3078F |
|
2,153 |
1,921 |
$0.00 |
| 3077F |
|
56 |
50 |
$0.00 |